Literature DB >> 32588747

Approximate Bayesian Bootstrap procedures to estimate multilevel treatment effects in observational studies with application to type 2 diabetes treatment regimens.

Anthony D Scotina1, Andrew R Zullo2, Robert J Smith3, Roee Gutman4.   

Abstract

Randomized clinical trials are considered as the gold standard for estimating causal effects. Nevertheless, in studies that are aimed at examining adverse effects of interventions, randomized trials are often impractical because of ethical and financial considerations. In observational studies, matching on the generalized propensity scores was proposed as a possible solution to estimate the treatment effects of multiple interventions. However, the derivation of point and interval estimates for these matching procedures can become complex with non-continuous or censored outcomes. We propose a novel Approximate Bayesian Bootstrap algorithm that results in statistically valid point and interval estimates of the treatment effects with categorical outcomes. The procedure relies on the estimated generalized propensity scores and multiply imputes the unobserved potential outcomes for each unit. In addition, we describe a corresponding interpretable sensitivity analysis to examine the unconfoundedness assumption. We apply this approach to examine the cardiovascular safety of common, real-world anti-diabetic treatment regimens for type 2 diabetes mellitus in a large observational database.

Entities:  

Keywords:  Approximate Bayesian Bootstrap; Causal inference; generalized propensity score; multiple imputation; multiple treatments

Mesh:

Year:  2020        PMID: 32588747     DOI: 10.1177/0962280220928109

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  1 in total

1.  Multiple imputation procedures for estimating causal effects with multiple treatments with application to the comparison of healthcare providers.

Authors:  Gabriella C Silva; Roee Gutman
Journal:  Stat Med       Date:  2021-11-02       Impact factor: 2.373

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.